State Of Alaska, Department Of Revenue Halozyme Therapeutics, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.42 Billion
- Q3 2024
A detailed history of State Of Alaska, Department Of Revenue transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 14,838 shares of HALO stock, worth $702,134. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,838
Previous 13,843
7.19%
Holding current value
$702,134
Previous $724,000
17.27%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding HALO
# of Institutions
543Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$834 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$610 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$314 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$192 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$161 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.59B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...